Boronic Acids
They are widely used in organic synthesis, particularly in Suzuki cross-coupling reactions and other boron-based transformations.
Boronic acids exhibit unique properties, such as the ability to form cyclic esters with diols and to interact with various nucleophiles.
This versatile class of compounds finds applications in medicinal chemistry, materials science, and biochemistry.
Researchers can explore the latest protocols and methods for working with boronic acids using AI-driven platforms like PubCompare.ai, which help identify the most reproducible and accurate appraoches from published literature, preprints, and patents.
Most cited protocols related to «Boronic Acids»
interest in pan-assay interference (PAINS)58 (link) SMARTS patterns recently. We used the RDKit version53 of the Guha translation57 (link) of
the original 480 PAINS expressed in Sybyl Line Notation (SLN).58 (link) All molecules in ZINC have been annotated and
are searchable by PAINS and other SMARTS patterns. We compute a reactivity molecular property from the pattern membership
of each molecule. The reactivity categories are A) anodyne; B) clean
(PAINS-ok); C) mild (weakly reactive, typically as a nucleophile or
electrophile); D) reactive; E) unstable or irrelevant for screening.
For E, we do not build molecular models for noncovalent docking (e.g.,
boronic acids). We also curated 40 patterns used by the prior version
of ZINC. SMARTS patterns are rendered using SMARTSViewer.110 (link)
For lectin enrichment, ConA and WGA-conjugated agarose beads (Vector Laboratories) were washed five times using the enrichment buffer (20 mM Tris-base, pH = 7.4, 0.15 M NaCl, 1 mM MgCl2, 1 mM CaCl2, and 1 mM MnCl2)35 (link). Peptides were dissolved in the enrichment buffer, mixed with the lectin beads, and vortexed at 37 oC for an hour. The beads were then washed again with the enrichment buffer five times before glycopeptide elution using the elution buffer (0.2 M α-methyl mannoside, 0.2 M α-methyl glucoside, 0.2 M galactose, and 0.5 M N-acetyl-
For HILIC enrichment, SeQuant® ZIC-HILIC SPE cartridges (the Nest Group) were washed with ten column volumes of 1.0% TFA in water, followed by three washes with the loading buffer (1.0% TFA in 80% ACN, 20% H2O)38 (link)–40 (link). Peptides were loaded onto the column in the loading buffer using a slow flow rate. The column was then washed with the loading buffer three times. Glycopeptides were eluted using 1.0% TFA in water three times, and the eluents were combined.
Most recents protocols related to «Boronic Acids»
Example 93
This compound was synthesized using 6-bromospiro[chromane-2,4′-piperidine]-1′-carboxamide (0.068 g, 0.21 mmol) and (1-tert-butoxycarbonylindol-3-yl)boronic acid (0.082 g, 0.31 mmol) to yield the desired compound as an off-white solid (0.076 g, 79%). Analysis: LCMS m/z=462 (M+1); 1H NMR (400 MHz, DMSO-d6) δ 8.14 (d, J=8.3 Hz, 1H), 7.83 (d, J=7.8 Hz, 1H), 7.76 (s, 1H), 7.45-7.36 (m, 3H), 7.35-7.28 (m, 1H), 6.91 (d, J=8.3 Hz, 1H), 5.96 (s, 2H), 3.69 (d, J=13.3 Hz, 2H), 3.20-3.08 (m, J=10.9, 10.9 Hz, 2H), 2.83 (t, J=6.7 Hz, 2H), 1.83 (t, J=6.8 Hz, 2H), 1.74-1.67 (m, 2H), 1.65 (s, 9H), 1.60-1.48 (m, 2H).
Example 92
This compound was synthesized using tert-butyl 6-bromospiro[4H-1,3-benzodioxine-2,4′-piperidine]-1′-carboxylate (0.100 g, 0.260 mmol) and (1-tert-butoxycarbonylindol-2-yl)boronic acid (0.102 g, 0.390 mmol) to yield the desired compound as an off-white foam (0.082 g, 61%). Analysis: LCMS m/z=521 (M+1); 1H NMR (400 MHz, DMSO-d6) δ 8.11-8.04 (m, 1H), 7.59 (d, J=7.3 Hz, 1H), 7.36-7.28 (m, 1H), 7.28-7.21 (m, 2H), 7.19 (d, J=2.0 Hz, 1H), 6.93 (d, J=8.3 Hz, 1H), 6.65 (s, 1H), 4.90 (s, 2H), 3.53-3.38 (m, 4H), 1.90-1.75 (m, 4H), 1.42 (s, 9H), 1.29 (s, 9H).
Example 14
A mixture of tert-butyl ((3R,5S)-1-(5-(2-chloropyrimidine-4-carboxamido)-2-methylbenzo[d]thiazol-4-yl)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate (Intermediate 13, 76 mg, 0.146 mmol), (2-cyano-6-methoxyphenyl)boronic acid (15.55 mg, 0.088 mmol), XPhos Pd G2 (57.6 mg, 0.073 mmol), potassium phosphate tribasic (62.2 mg, 0.293 mmol), 1,4-dioxane (1 mL), and water (0.2 mL) was purged under nitrogen and stirred at 80° C. for 2 hrs. After cooling to r.t., the reaction mixture was concentrated and TFA (1 mL) was added and the resulting mixture was stirred at r.t. for 30 minutes. The reaction mixture was then diluted with acetonitrile and purified with prep-LCMS (XBridge C18 column, eluting with a gradient of acetonitrile/water containing 0.1% TFA, at flow rate of 60 mL/min). LCMS calculated for C26H28N7O4S (M+H)+: m/z=534.2; Found: 534.2.
Example 49
Synthesis of AM362-A.
To a degassed mixture of tert-butyl 5-bromoisoindoline-2-carboxylate (1 g, 3.3 mmol), 1-methyl-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester (1.12 g, 5.031 mmol) and Cs2CO3 (3.2 g, 9.9 mmol) in 1,4-dioxane (10 mL) was added Pd(dppf)Cl2 under N2 atmosphere and the mixture was heated at 95° C. overnight. The reaction mixture was diluted with DCM (25 mL) and the catalyst was removed by filtration through the celite. The filtrate was concentrated in vacuo and the residue was purified by column chromatography on silica gel (PE:EtOAc=80:20˜60:40) to give AM362-A (0.8 g, 76%) as a brown gum.
Compound AM362 (450 mg, 95%, a brown solid) was synthesized in a similar procedure used for AM351 from AM351-D.
Compound AM403 (250 mg, 96%, a yellow solid) was synthesized in a similar manner using the appropriately substituted boronic acid pinacol ester variant of AM362.
Example 31
To a solution of 4-((5-bromo-2-(4-fluorophenoxy)benzamido)methyl)benzoic acid (80 mg, 1.0 eq) and (3-cyano-5-fluorophenyl)boronic acid (59 mg, 2.0 eq) in DMF (1.2 mL) 2M Cs2CO3 (0.27 mL, 3.0 eq) and Pd(dppf)Cl2·DCM (9 mg, 0.06 eq) under nitrogen atmosphere. After stirred at 110° C. for 20 h, the mixture was filtered through celite, rinsing with ethyl acetate (20 mL). The organic phase was washed with sat. aq. sodium bicarbonate (20 mL) and brine (20 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. The crude material was purified by flash column chromatography (Hexanes:ethyl acetate, 1:1) to obtain the acid IV-484-536 as white solid (22 mg, 25.2% yield).
1H-NMR (400 MHz, DMSO-d6): δ=12.86 (s, 1H), 8.99 (t, 1H), 8.12 (s, 1H), 8.07 (d, 2H), 8.01 (dd, 1H), 7.89 (dd, 1H), 7.84 (d, 2H), 7.39 (d, 2H), 7.27 (m, 2H), 7.16 (m, 2H), 6.99 (d, 1H), 4.54 (d, 2H).
HPLC-MS: Rt 2.23 m/z 485.1 (MH+)
Top products related to «Boronic Acids»
More about "Boronic Acids"
These chemical entities have gained significant attention in the realms of organic synthesis, medicinal chemistry, materials science, and biochemistry.
One of the key applications of boronic acids is their use in Suzuki cross-coupling reactions, a widely employed method in organic synthesis.
Additionally, boronic acids exhibit unique properties, such as the ability to form cyclic esters with diols and to interact with various nucleophiles, making them valuable tools for researchers.
Boronic acid-based compounds have found applications in diverse areas, including the development of pharmaceutical agents, sensors, and materials.
For instance, Coumarin Boronic Acid (CBA) is a boronic acid derivative that has been investigated for its potential use in fluorescent probes and bioimaging applications.
When working with boronic acids, researchers can utilize advanced platforms like PubCompare.ai, which leverages artificial intelligence to identify the most reproducible and accurate protocols from published literature, preprints, and patents.
This can help optimize workflows and enhance research efficiency.
Furthermore, related terms and techniques, such as HPLC (High-Performance Liquid Chromatography), C8 and C18 stationary phases (e.g., XBridge C8, Gemini C18, Synergi C18), and chemical additives (e.g., Taurine, K2CO3), can be employed in the analysis and purification of boronic acid-containing compounds.
By exploring the versatility and applications of boronic acids, researchers can unlock new possibilities in their respective fields, advancing our understanding and utilization of these remarkable chemical entities.